Business Wire

EVIDON-INC.

Share
Evidon Announces GDPR Partnership Programme With Leading Law & Consulting Firms

Today, Evidon , Inc., the global leader in simplifying the complex world of Digital Governance, Risk and Compliance, announced the creation of the Evidon General Data Protection Regulation (GDPR) Partnership Programme. This programme brings together top-tier law firms and consulting firms to give them access to Evidon’s industry-standard GDPR software solutions. These technologies help organisations worldwide to comply with complex privacy laws and digital governance challenges, from collecting data to acquiring consent.

Evidon’s new GDPR Partnership Programme provides participants with exclusive benefits. Evidon's Trackermap® provides on-demand page and tag-level analysis to govern and manage risk of data flows and reliability from complex vendor networks. Trackermap has become an industry standard for Privacy Impact Assessments and GDPR Readiness Assessments. Additionally, partners can use Evidon’s full website monitoring and scanning solution of all third-party tracking technology, as well as Evidon’s GDPR Digital Governance Assessment. Partners will also be actively engaged in the development of Evidon’s update to its patented Consumer Consent solution to comply with the GDPR and pending ePrivacy Regulation.

Evidon CEO Scott Meyer says, “Law firms and consulting firms are busier than ever with GDPR Readiness Assessments, Privacy Impact Assessments and prioritising next steps to be GDPR-ready by May 2018. With so many already relying on Evidon technology and expertise, we’re thrilled to make our Trackermap and other tools available to make this effort easier and more productive.”

Evidon’s GDPR products are relied upon by many organisations as must-have tools to help them get ready for the GDPR. "We use the Evidon Trackermap as a key part of our GDPR assessment process," says Heather Sussman of Ropes & Gray LLC. “It’s a valuable resource for helping our clients bring their digital supply chain under control.”

Charter partners in the programme include Alston & Bird LLP, ZwillGen, UnitedLex, Ropes & Gray LLP, WireWheel, Davis & Gilbert LLP, Hogan Lovells LLP, Loeb & Loeb, LLC and Winston & Strawn LLP.

For more information how to participate in Evidon’s GDPR Partnership Programme, contact Evidon at sales@evidon.com or +001 917 262 2530.

About Evidon

Evidon is a global technology company focused on simplifying the complex world of Digital Governance, Risk & Compliance (GRC). As companies add more marketing and advertising technology to maximise the return on their digital investment, building consumer trust has become ever more important. Fulfilling this promise requires organisations to have a comprehensive approach to govern data collection across their sites, apps, and ads while staying in compliance with global regulations. The world’s leading brands rely on Evidon to empower their Digital GRC success across millions of web pages and apps that drive billions of online revenue.

Contact:

For Evidon
Beki Morgan, GingerMay PR
rebecca.morgan@gingermaypr.com
0044 203 642 1124

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Leading law firm launches industry first social justice fund10.6.2025 07:00:00 CEST | Press release

Initiative sets a new precedent that funds legal support for vulnerable individuals, while meeting the needs of business clients seeking socially responsible suppliers. Bindmans, an award-winning multidisciplinary law firm with a 50-year human rights and social justice record, has today set a new precedent in the legal industry by announcing the launch of its 10% Social Justice Fund (SJF). The fund will allocate 10% of business client fees to support individuals in gaining access to justice. It marks an industry first and serves the joint purpose of helping to improve the Environmental, Social, and Governance (ESG) scores of Bindmans’ corporate clients, enhancing their impact across the value chain through socially responsible legal services. Bindmans has a proud record in human rights and social justice, dedicated to providing legal services to those who need it most. The law firm was founded 50 years ago by one of the greatest Human Rights lawyers in the UK, Sir Geoffrey Bindman (KC)

FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem10.6.2025 06:17:00 CEST | Press release

Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum - HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough innovations in science, technology, and AI to accelerate healthcare advancements and drive digital transformation in public health services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609760138/en/ FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem The Forum was attended by Vietnam Deputy PM H.E. Le Thanh Long, key government officials, and international guests including U.S. Ambassador Marc Knapper, Swiss Ambassador Thomas Gass, former German Vice Chancellor Dr. Philipp Rösler, and representatives from Japan, Singapore, and Harvard Medical School. Vietnam Deputy PM H.E. Le Thanh Long stressed the urgent need to reform healthcare, outlining five strategies: accelerate digitaliza

China’s Center for Drug Evaluation Accepts Merck’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor10.6.2025 06:00:00 CEST | Press release

First global filing for potentially best-in-class TGCT treatment based on strong positive data from Phase 3 MANEUVER study Potential for pimicotinib to be first systemic TGCT therapy approved in China, following recent granting of Priority Review by CDEAdditional applications planned in the US and other markets around the world Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to pimicotinib by the CDE in May for the treatment of patients with TGCT who require systemic therapy, which is expected to expedite the review process. Pimicotinib, a potentially best-in-c

KuppingerCole Recognizes Regula as One of the Innovation Leaders in Identity Verification10.6.2025 03:00:00 CEST | Press release

Regula, a global developer of forensic devices and identity verification (IDV) solutions, has made its inaugural appearance in the KuppingerCole Leadership Compass for Identity Verification 2025. Mentioned in the Innovation Leaders category, the company is recognized for its 100% in-house R&D, forensic-grade technology, global document coverage, and advanced liveness detection capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609760424/en/ Regula’s innovative in-house technology powers fast, seamless identity checks—now recognized by KuppingerCole Analysts. Specializing in IDV and cybersecurity industry analysis, KuppingerCole forecasts that the global IDV market will grow from $18.4 billion in 2025 to $50.07 billion by 2030, driven by increasing identity fraud, compliance requirements, user expectations, and technological advancements. As identity verification rapidly shifts toward fully remote and automated e

IFF Appoints Virginia “Gina” Drosos to Board of Directors9.6.2025 23:46:00 CEST | Press release

IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos brings more than 30 years of executive leadership experience across the retail, consumer goods, beauty and health care industries. “We are very pleased to welcome Gina to the IFF board,” said Kevin O’Byrne, chair of the board. “Gina brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders.” Drosos most recently served as chief executive officer and a director of Signet Jewelers Ltd. (NYSE: SIG)—the world’s largest retailer of diamond jewelry—from August 2017 to November 2024. During her tenure, she led the company through a significant transformation, expanding its digital capabilities and enhancing customer experien

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye